Last updated on July 2020

Phase II Open Label Study of IMMU-132 in Metastatic Urothelial Cancer


Find a site near you

Start Over

Weill Cornell Medicine

New York, NY United States
  Connect »

Urology Cancer Center

Omaha, NE United States
  Connect »

Woodlands Medical Specialists

Pensacola, FL United States
  Connect »

Winship Cancer Institute

Atlanta, GA United States
  Connect »

Norton Cancer Institute

Louisville, KY United States
  Connect »

Northwell Health

Lake Success, NY United States
  Connect »

Stony Brook Medicine Cancer Care

Stony Brook, NY United States
  Connect »

Houston Methodist Hospital

Houston, TX United States
  Connect »

Huntsman Cancer Hospital

Salt Lake City, UT United States
  Connect »

Blue Ridge Cancer Care

Roanoke, VA United States
  Connect »

Gustave Roussy

Villejuif, France
  Connect »

Institut Curie

Paris Cedex 05, France
  Connect »

Hopital Foch

Suresnes, France
  Connect »

Centre Le'on Be'rard

Lyon Cedex 08, France
  Connect »

National Cancer Center

Goyang-si, Korea, Republic of
  Connect »

Severance Hospital

Seoul, Korea, Republic of
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.